Tumblelog by Soup.io
Newer posts are loading.
You are at the newest post.
Click here to check if anything new just came in.
rafeykeith

Theravance Biopharma And Sciclone Pharmaceuticals Enter Into Development And Commercialization Agreement For Vibativ(r) (telavancin) In China - Yahoo Finance

SciClone Pharmaceuticals and Theravance Biopharma Enter Into Development and Commercialization Agreement for VIBATIV(R) (Telavancin) in China - Yahoo Finance

VIBATIV for injection is approved in the U.S. for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by susceptible isolates of Staphylococcus aureus when alternative treatments are not suitable. In addition, VIBATIV is approved in the U.S. for the treatment of adult patients with complicated skin & skin structure infections (cSSSI) caused by susceptible isolates of Gram-positive bacteria, including Staphylococcus aureus, both methicillin-susceptible (MSSA) and methicillin-resistant (MRSA) strains.
For mrsa early stages the original version including any supplementary images or video, visit http://finance.yahoo.com/news/sciclone-pharmaceuticals-theravance-biopharma-enter-120500246.html

Infusion Related Reactions VIBATIV is a lipoglycopeptide antibacterial agent and should be administered over a period of 60 minutes to reduce the risk of infusion-related reactions. Rapid intravenous infusions of the glycopeptide class of antimicrobial agents can cause mrsa after surgery "Red-man Syndrome" like reactions including: flushing of the upper body, urticaria, pruritus, or rash. QTc Prolongation Caution is warranted when prescribing VIBATIV to patients taking drugs known to prolong the QT interval. In a study involving healthy volunteers, VIBATIV prolonged the QTc interval.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/theravance-biopharma-sciclone-pharmaceuticals-enter-120500612.html

The New Global Strategy to Counter Drug-Resistant Microbes

In response, researchers develop new and more effective drugs, or switch between treatment regimens in hopes of outflanking microbial evolution. Its an arms race, and were not winning . Countering that resistance could require more expensive drugs, which puts a strain on patients and the healthcare system as a whole.
For the original version including any supplementary images or video, visit http://gizmodo.com/the-new-global-strategy-to-counter-antimicrobial-resist-1706944735

Consumer Reports finds harmful bacteria in frozen shrimp | abc7.com

Overall, 60 percent of the raw shrimp samples tested positive for bacteria, so safe preparation is very important. And 11 samples, or about five percent of imported, raw, farmed shrimp, had antibiotic residues. "The antibiotic use is particularly troubling because it's illegal, it promotes antibiotic resistance, and it just isn't a responsible way of farming," Rangan said. Consumer Reports recommends buying responsibly sourced wild shrimp, like those recommended by Seafood Watch or certified by the Marine Stewardship Council. If farmed shrimp are better for your budget, Consumer Reports says look for farmed shrimp certified by Naturland, the Aquaculture Stewardship Council, or Whole Foods Market Responsibly Farmed.
For the original version including any supplementary images or video, visit http://abc7.com/food/consumer-reports-finds-harmful-bacteria-in-frozen-shrimp/741368/

Roche receives FDA clearance for the cobas® Cdiff Test to detect Clostridium difficile -- PLEASANTON, Calif., May 26, 2015 /PRNewswire/ --

About Roche Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients.
For the original version including any supplementary images or video, visit http://www.prnewswire.com/news-releases/roche-receives-fda-clearance-for-the-cobas-cdiff-test-to-detect-clostridium-difficile-300088360.html

Don't be the product, buy the product!

Schweinderl